SPLF Webmaster

2021/03/25 – 11h30

>>> COVID-19-Docs english version

Les articles de la Revue Respiratory Medicine and Research
© 2020 SPLF and Elsevier Masson SAS. All rights reserved.

• Venous thromboembolism and COVID-19  (pdf)
https://doi.org/10.1016/j.resmer.2020.100759 2590-0412
Keywords : Coronavirus disease – COVID-19 – SARS-CoV-2 – Pulmonary embolism – Venous thromboembolic disease 

• Respiratory support in patients with COVID-19 (outside intensive care unit). A position paper of the Respiratory Support and Chronic Care Group of the French Society of Respiratory Diseases (pdf)
https://doi.org/10.1016/j.resmer.2020.100768 
Keywords :

• Pulmonary embolism among critically ill patients withARDS due to COVID-19 (pdf)
https://doi.org/10.1016/j.resmer.2020.100789
Keywords : 

• Proposals for managing patients with thoracic malignancies during COVID-19 pandemic (pdf)
https://doi.org/10.1016/j.resmer.2020.100769
Keywords : 

• Prognostic value of lung ultrasound and its link with inflammatory biomarkers in patients with SARS-CoV-2 infection (pdf)
https://doi.org/10.1016/j.resmer.2020.100809
Keywords : 

• Paediatric aspects of COVID-19: An update (pdf)
https://doi.org/10.1016/j.resmer.2020.100765 
Keywords : COVID 19 – Paediatric: Clinical aspects

• Nebulization: A potential source of SARS-CoV-2 transmission (pdf)
https://doi.org/10.1016/j.resmer.2020.100778 
Keywords : Polyenes – Mucorales – Antifungal drugs – Azoles – Prophylaxis – Nebulization 

• Management of asthma during the Coronavirus disease 2019 outbreak (pdf)
https://doi.org/10.1016/j.resmer.2020.100762 
Keywords : Asthma – Covid19 

• Letter to the Editor in response to the article: “Nebuliza-tion: a potential source of SARS-CoV-2 transmission” (pdf)
https://doi.org/10.1016/j.resmer.2020.100802 
Keywords :

• Impact of the Covid-19 pandemic and lung transplantation program in France (pdf)
https://doi.org/10.1016/j.resmer.2020.100758 
Keywords : Lung Transplantation – COVID 19 – SARS-CoV-2 – Drug shortage – Telemedicine 

• Impact of the COVID-19 lockdown on patients suffering from idiopathic interstitial pneumonia (pdf)
https://doi.org/10.1016/j.resmer.2020.100808 
Keywords : COVID-19 – Lockdown – Idiopathic interstitial pneumonia – Idiopathic pulmonary fibrosis 

• Immunosuppression in a lung transplant recipient withCOVID-19? Lessons from an early casea (pdf)
https://doi.org/10.1016/j.resmer.2020.100782 
Keywords : SARS-CoV-2 – Lung transplantation – Immunosuppressants – Protease inhibitors –Therapeutic drug monitoring

• Delayed pulmonary abscess following COVID-19 pneumonia: A case report  (pdf)
https://doi.org/10.1016/j.resmer.2020.100776 
Keywords : COVID-19 – Pneumonia Pulmonary abscess

• COVID-19 spread: The Italian case (pdf)
https://doi.org/10.1016/j.resmer.2020.100771 
Keywords : Covid-19 – Pneumonia 

• Covid-19 pneumonia and pulmonary vascular disease: A UK Centre perspective (pdf)
https://doi.org/10.1016/j.resmer.2020.100781 
Keywords :  Coronavirus – Pulmonary hypertension – Royal Brompton Hospital London UK – Pulmonary embolism – Intensive care – ECMO – Guidelines 

• COVID-19 in a patient with idiopathic pulmonary fibro-sis successfully treated with Ruxolitiniba  (pdf)
https://doi.org/10.1016/j.resmer.2020.100799
Keywords : SARS-CoV-2 – Covid-19 – JAK inhibitors – Idiopathic pulmonary fibrosis

• COVID-19 and Pneumocystis jirovecii pneumonia: Backto the basicsa  (pdf)
https://doi.org/10.1016/j.resmer.2021.100814 
Keywords : COVID-19 – Pneumocystis – Jirovecii – Pneumocystosis

• Covid-19: Adapting the geriatric organisations to respond to the pandemic (pdf)
https://doi.org/10.1016/j.resmer.2020.100774 
Keywords : Coronavirus disease – Covid-19SARS-CoV-2 – Elderly. 

• Clinical characteristics of and outcomes for patients with COVID-19 and comorbid lung diseases primarily hospitalized in a conventional pulmonology unit: A retrospective study (pdf)
https://doi.org/10.1016/j.resmer.2020.100801 

• Chronic obstructive pulmonary disease and the COVID-19 pandemic: Reciprocal challenges (pdf)
https://doi.org/10.1016/j.resmer.2020.100764 
Keywords :  COPD – COVID-19 – Infection 

• Bronchoscopy use in the COVID-19 era (pdf)
https://doi.org/10.1016/j.resmer.2020.100760 

• Alveolar lymphocytosis with plasmacytosis in severeCOVID-19 (pdf) 
https://doi.org/10.1016/j.resmer.2020.100784 
Keywords :   COVID-19 – SARS-CoV-2 – Pneumonia – Bronchoalveolar lavage fluid – Critical care 

• A severe COVID-19 despite ongoing treatment with Lopinavir-Ritonavira  (pdf)
https://doi.org/10.1016/j.resmer.2020.100780 
Keywords : COVID-19 – Human immunodeficiency virus – Lopinavir – Pneumonia – Pulmonary embolism

Documents en anglais  émanants des groupes de travail  de la SPLF 

• Procedure for the pulmonary management of non-ICU patients hospitalized in the context of the COVID-19 pandemic
C. Rabec, J.Gonzalez-Bermejo for the working group (GAVO2) of SPLF
• Proposals for the management of COPD patients in the context of the COVID-19 epidemic G (pdf)
Deslée, M Zysman, L Boyer, N Roche, PR Burgel for the COPD group  Version dated 29/03/2020
• Proposals for managing patients in the context of the COVID-19 pandemic (pdf)
Writing: group of experts including the French Oncology group, the SPLF and the IFCT as 
• Position of the Asthma and Allergy Working Group (G2A) of the SPLF on the management of asthma patients during the COVID-19 epidemic (pdf)
• Information note on the use of nebulizers during the Covid-19 epidemic (pdf)
JC Dubus, G Reychler, L Vecellio; on March 15, 2020  for the working group on aerosol therapy (GAT) of SPLF